DEVELOPMENT, OPTIMIZATION AND EVALUATION OF HERBAL GEL FORMULATION
HTML Full TextDEVELOPMENT, OPTIMIZATION AND EVALUATION OF HERBAL GEL FORMULATION
Kinjal Patel * and Maitreyi Zaveri
Department of Pharmacognosy, K. B. Institute of Pharmaceutical Education and Research, Kadi Sarva Vishwa Vidyalaya, Gandhinagar, Gujarat, India.
ABSTRACT: Acne vulgaris is one of the most common chronic inflammatory skin diseases affecting more than 85% of adolescents worldwide. Quercetin, curcuminoids, and berberine HCl have anti-acne, anti-inflammatory, antibacterial, and antioxidant characteristics. This study aimed to develop, optimize and evaluate herbal gel containing quercetin, curcuminoids, and berberine HCl. A preliminary trial was conducted for the screening of polymers. A 32 full factorial design was applied to investigate the combined effect of the two independent variables, i.e., the concentration of carbopol 934 and the concentration of propylene glycol, on the dependent variables viscosity and cumulative percent drug release at 8 hrs. The optimized formulation (D0) shows a viscosity of 78123.67±0.69 cps, cumulative percent drug release of quercetin 85.99±1.03%, berberine HCl 35.38± 0.45% and curcuminoids 70.28± 1.18%. An FTIR investigation of drug excipient compatibility revealed no interactions between drugs and excipients. Based on all parameters and experimental design evaluations, it was determined that viscosity increased with increasing carbopol 934 and propylene glycol concentrations; cumulative percent drug release decreased with increasing carbopol 934 concentrations and increased with increasing propylene glycol concentrations.
Keywords: Acne, Carbopol 934, Propylene glycol, Quercetin, Curcuminoids, Berberine HCl
INTRODUCTION: Acne vulgaris is a common skin disorder, due to chronic inflammation of sebaceous follicles, is characterized by tender inflammatory papules and nodules. Acne usually arises on the face, forehead, chest, upper back, and shoulders since these are the areas of skin with the most oil glands. According to the Global Burden of Disease research, acne vulgaris affects more than 85 percent of young people worldwide and can strike at any age. It typically appears throughout puberty and worsens during adolescence and is classified as an adolescent disease that affects almost 80% of the population between the ages of 11 to 30 1, 2, 3.
Acne is treated with retinoids, topical or systemic antibiotics, and other medications. The most serious issue with antibiotic use is resistance and its consequences; oral isotretinoin is teratogenic 4. Plants are a natural source of medicine that can be utilized to treat a wide range of dermatological problems due to their efficacy and devoid of side effects 5.
Based on literature evaluations, we selected quercetin, curcuminoids, and berberine HCl for herbal gel formulation since they have anti-inflammatory, anti-acne, antibacterial, and antioxidant characteristics 6-12. As a result, this study aimed to develop, optimize and evaluate herbal gel formulation for acne treatment.
MATERIAL AND METHODS:
Reagents and Chemicals: Quercetin, berberine HCl and curcuminoids were procured from Yucca enterprises, Mumbai; Sodium alginate, Na CMC and HPMC K100M were procured from Astron chemicals (India); HEC were procured from Yarrow chem product, Mumbai; Carbopol 934 were procured from Research-lab fine chem Industries; Propylene glycol and Triethanolamine were procured from S.D. fine chemicals, Mumbai.
Drug Excipients Compatibility Study using FTIR: The IR spectra were acquired using an FTIR using the KBr pellet technique, and the wavelength range was between 4000 and 400 cm-1. The spectra obtained for drugs and physical mixtures of drugs with polymers were observed 13.
Screening of Polymers: Preliminary screening was performed to confirm the effect of various polymers on herbal gel formulation Composition of preliminary trial batches of herbal gel is shown in Table 1. The resulting gel was evaluated for viscosity, homogeneity, and clarity 14-18.
TABLE 1: PRELIMINARY TRIAL BATCHES OF HERBAL GEL FOR SCREENING OF POLYMERS
Ingredients | Composition (%w/w) | ||||||||||||||
F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | |
Carbopol 934 | 0.5 | 1 | 2 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
HPMC K100M | -- | -- | -- | 2 | 3 | 4 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
HEC | -- | -- | -- | -- | -- | -- | 1 | 2 | 3 | -- | -- | -- | -- | -- | -- |
Na CMC | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4 | 5 | 6 | |||
Sodium alginate | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5 | 6 | 7 |
Triethanolamine | q.s. | q.s. | q.s. | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Propylene glycol | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Distilled water q.s to make | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
HPMC K100M- Hydroxy propyl methyl cellulose K100M, HEC- Hydroxy ethyl cellulose, Na CMC- Sodium carboxy methyl cellulose.
Optimization of Formulation as Per 32 Full Factorial Design: A 32 full factorial design was applied for optimization of the formulation. The concentration of carbopol 934 and the concentration of propylene glycol was taken as independent variables; viscosity and cumulative percent drug release at 8 hrs (Q8) were taken as dependent variables. We evaluated the response using a statistical model that included interactive and polynomial terms Table 2.
TABLE 2: VARIABLES IN 32 FULL FACTORIAL DESIGN
Independent variables | Levels | ||
-1 (Low) | 0 (Medium) | 1 (High) | |
X1= concentration of carbopol | 0.75 gm | 1 gm | 1.25 gm |
X2= Concentration of propylene glycol | 5 gm | 10 gm | 15 gm |
Method of Preparation of Gel Formulation: Weighed quantity of carbopol 934 was soaked overnight in purified water containing sodium benzoate to ensure complete swelling of the polymer. Then propylene glycol was added. Drugs were accurately weighed and dissolved in ethanol in a stoppered glass vial, slowly added to the polymeric mixture, and homogenized in Triethanolamine was added in an amount (q.s.) sufficient to neutralize the pH. Then, distilled water was added to make q.s. to 100 gm with continuous stirring using mechanical stirrers Composition of factorial batches is shown in Table 3 14, 15, 16, 18.
TABLE 3: COMPOSITION OF FACTORIAL BATCHES
Ingredients | Composition (%w/w) | ||||||||
D1 | D2 | D3 | D4 | D5 | D6 | D7 | D8 | D9 | |
Quercetin | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 |
Berberine HCl | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Curcuminoids | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Carbopol 934 | 0.75 | 1 | 1.25 | 0.75 | 1 | 1.25 | 0.75 | 1 | 1.25 |
Propylene glycol | 5 | 5 | 5 | 10 | 10 | 10 | 15 | 15 | 15 |
Sodium benzoate | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Triethanolamine | q.s. | q.s. | q.s. | q.s. | q.s. | q.s. | q.s. | q.s. | q.s. |
Distilled water q.s. to make | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Evaluation of Gel:
Viscosity: The viscosity of the gel formulation was determined at a temperature of 25.0 ± 0.5 °C using a viscometer (Brookfield DV-III+ Rheometer TC-502 Temperature Controller, USA). Spindle speeds have been adjusted to give the highest torque values in the 10-100% range, as the Brookfield instruction manual recommended. Viscosity was measured using spindles # 64 and 5 rpm 15, 18.
Homogeneity: Visual inspection in the presence of light techniques was adopted to check the homogeneity of gel 18.
pH Measurement: After calibration of pH meter using standard buffer solution at pH 4, 7, 9; the determinations were carried out in triplicate by dipping the glass electrode entirely into the formulation, and the average was calculated 18.
Spreadability: The gel was transferred to a glass slide and covered with an equivalent slide. The slides are arranged to have the gel interposed up to 7.5 cm. A weight of 100 g was placed over the upper slide, which helped in forming a uniform thin layer. The weight was removed, and excess adhering gel was wiped. After that 20 g weight was coupled carefully to upper slide. Time taken to travel a distance of 7.5 cm by upper slide under the influence of weight was recorded. The following formula was used to determine spreadability.
S = M x L / T
Where, S - Spreadability M - Weight coupled to the upper slide (20 g) L - Length of the glass slide (7.5 cm) T- Time is taken to separate the slides in seconds 19.
Drug Content: The drug content of the gel was determined by dissolving 0.5 g of the gel in 50 ml of phosphate buffer pH 7.4. The solution was diluted with phosphate buffer pH 7.4 and filtered through a 0.45 µm membrane filter. Absorbance was measured using Shimadzu1800 UV visible spectrophotometer 15.
In-vitro Drug Release Study: Franz diffusion cell was used for in vitro drug release studies having a receptor compartment capacity of 22.6 ml and an effective diffusion area of 4.52 cm2. The cellophane membrane of the required thickness was hydrated for 24 hours before use with phosphate buffer pH 7.4. The donor compartment contained 1 g gel, and the recipient compartment contained phosphate buffer pH 7.4. The whole assembly was fixed on a magnetic stirrer, and the solutions in the receptor compartment were continuously stirred using magnetic beads at 50 rpm, and the temperature was maintained at 35±0.5 °C. At regular intervals, sampling was done from the receptor compartment, and an equal volume of fresh phosphate buffer pH 7.4 was added to the receptor compartment. The spectrophotometric method measured the active ingredient contained in the collected sample. The cumulative percentage of drug release was plotted against time 15.
Optimization of Formulation: Optimization of the formulation was done by the software Design Expert 6.0.8 Portable.
Accelerated Stability Study: Accelerated stability study was conducted for optimized gel at 40°C and 75% RH for three months using a humidity chamber. The gel was analyzed for pH, viscosity, and drug content 20.
RESULTS AND DISCUSSION:
Drug Excipients Compatibility Study using FTIR: IR studies have identified key functional group IR bands of pure drugs and physical mixtures and studied the physical and chemical interactions between drugs and the excipients used.
FIG. 1(A): IR SPECTRA OF MIXTURE OF DRUGS; 1(B): IR SPECTRA OF MIXTURE OF DRUGS AND POLYMER
It has been observed that the IR band of the characteristic drug remains unchanged in the IR spectrum of the physical mixture of drug and polymer. IR analysis showed that the drug and polymer are compatible Fig. 1A, 1B.
Screening of Polymers: All preliminary trial batches of gel show viscosity variation ranging from 800 to 190000 cps.
The pH values of all prepared formulations range from 6 to 7, which are considered acceptable to avoid the risk of irritation upon application to the skin. Of the five polymers, batch F2 showed optimum viscosity, good clarity, and homogeneity. Therefore, carbopol 934 was chosen for optimization Results of preliminary trial batches of herbal gel is shown in Table 4.
TABLE 4: RESULTS OF PRELIMINARY TRIAL BATCHES OF HERBAL GEL FOR SCREENING OF POLYMERS
Batch code | Viscosity(cps)± SD (n=3) | Homogeneity | Clarity |
F1 | 22490±1.63 | +++ | +++ |
F2 | 86370±0.82 | +++ | +++ |
F3 | 132000±1.05 | ++ | +++ |
F4 | 55434.33±2.49 | +++ | ++ |
F5 | 93580.33±2.05 | +++ | ++ |
F6 | 190000±1.98 | ++ | ++ |
F7 | 15998±2.16 | +++ | ++ |
F8 | 25600.33±1.25 | +++ | + |
F9 | 70299.67±2.05 | ++ | + |
F10 | 800±1.63 | ++ | ++ |
F11 | 1022.33±2.05 | ++ | ++ |
F12 | 1120±1.63 | ++ | ++ |
F13 | 7000±0.82 | + | + |
F14 | 23000±2.45 | + | + |
F15 | 55700±1.63 | + | + |
-Not satisfactory, + satisfactory, ++good, +++very good
Evaluation of 32 full Factorial Design Batches of Herbal Gel: The factorial design batches were evaluated for viscosity, homogeneity, pH, spreadability, drug content, and cumulative % drug release at 8 hrs Results of 32 full factorial design batches of herbal gel is shown in Table 5, 6.
TABLE 5: RESULTS OF 32 FULL FACTORIAL DESIGN BATCHES OF HERBAL GEL
Batch code | Viscosity (cps)± SD (n=3) | Homogeneity | pH± SD (n=3) | Spreadability
(cm.gm/sec) |
%Drug Content | ||
Quercetin | Berberine HCl | Curcuminoids | |||||
D1 | 24877.3±1.25 | +++ | 6.23±0.25 | 5.77 | 99.89±0.38 | 100.05±1.02 | 99.53±0.34 |
D2 | 57066±1.63 | +++ | 6.53±0.30 | 5.36 | 98.58±1.00 | 99.39±1.42 | 99.87±0.44 |
D3 | 67078.3±1.25 | +++ | 6.23±0.25 | 4.69 | 98.8±1.65 | 100.09±0.73 | 99.7±0.33 |
D4 | 49566.3±2.05 | +++ | 6.8±0.26 | 5.17 | 99.89±0.38 | 101.03±0.54 | 100.05±0.25 |
D5 | 73598±2.45 | +++ | 6.3±0.17 | 4.54 | 101.05±1.00 | 101.97±1.27 | 99.26±0.54 |
D6 | 98934±1.63 | +++ | 6.16±0.15 | 4.41 | 98.37±0.66 | 101.62±1.61 | 99.37±0.73 |
D7 | 78768.7±2.49 | ++ | 6.13±0.25 | 4.84 | 100.06±1.36 | 99.39±1.14 | 100.09±0.63 |
D8 | 97948.3±2.87 | ++ | 6.23±0.06 | 4.55 | 99.67±1.31 | 98.1±0.35 | 98.75±0.25 |
D9 | 1,34000±1.98 | ++ | 6.87±0.12 | 3.94 | 98.15±0.38 | 99.98±0.73 | 99.76±0.34 |
TABLE 6: EXPERIMENTAL RUNS AND MEASURED RESPONSES OF 32 FULL FACTORIAL DESIGN BATCHES OF HERBAL GEL
Batch code | X1=
Concentration of carbopol 934 (gm) |
X2= concentration of propylene glycol (gm) | Viscosity
(cps) |
Cumulative percentage drug release at 8 hrs | ||
Quercetin | Berberine HCl | Curcuminoids | ||||
D1 | 0.75 | 5 | 24877.3±1.25 | 66.51±0.72 | 28.83±0.92 | 53.87±0.91 |
D2 | 1 | 5 | 57066±1.63 | 59.56±0.51 | 26.49±0.88 | 49.49±0.89 |
D3 | 1.25 | 5 | 67078.3±1.25 | 51.94±0.77 | 22.41±0.72 | 43.58±0.85 |
D4 | 0.75 | 10 | 49566.3±2.05 | 85.41±0.87 | 35.54±0.83 | 68.04±1.01 |
D5 | 1 | 10 | 73598±2.45 | 78.34±0.94 | 32.09±1.71 | 61.08±0.95 |
D6 | 1.25 | 10 | 98934±1.63 | 73.31±0.96 | 29.47±0.85 | 55.44±1.16 |
D7 | 0.75 | 15 | 78768.7±2.49 | 89.21±0.94 | 37.52±1.16 | 69.15±1.14 |
D8 | 1 | 15 | 97948.3±2.87 | 79.21±0.52 | 33.71±1.05 | 63.05±1.25 |
D9 | 1.25 | 15 | 1,34000±1.98 | 72.18±0.78 | 30.15±1.47 | 56.89±1.15 |
FIG. 2: CUMULATIVE PERCENTAGE RELEASE OF QUERCETIN AT 8 HRS
FIG. 3: CUMULATIVE PERCENTAGE RELEASE OF BERBERINE HCL AT 8 HRS
FIG. 4: CUMULATIVE PERCENTAGE RELEASE OF CURCUMINOIDS AT 8 HRS
Regression Analysis:
Regression Analysis for the Effect of X1 and X2 on Y1 (Viscosity): The higher values of correlation coefficients for viscosity indicate a good fit. Here p Value for X1 and X2 was less than 0.05. Therefore, Carbopol 934 and propylene glycol significantly affected viscosity Results for regression statistics Y1 is shown in Table 7. From the 3D surface plot Fig. 5 and regression coefficient values of factors, it was concluded that carbopol 934 and propylene glycol positively affected viscosity. Here the b2 value is more positive than the b1 value, indicating that viscosity increases with increasing amounts of propylene glycol compared to carbopol 934 21, 22, 23.
FIG. 5: 3D SURFACE PLOT OF RESPONSE Y1
TABLE 7: REGRESSION STATISTICS Y1
R-Squared | 0.976 | |
Adj R-Squared | 0.971 | |
Source | Sum of Squares | P value |
Model (Linear) | 79493 | < 0.0001 |
X1 | 35918 | < 0.0001 |
X2 | 43575 | < 0.0001 |
Full model equation Y1=75094.38+ 24466.83X1+26949.17X2
Regression Analysis for the Effect of X1 and X2 on Y2 (Cumulative Percentage Release of Quercetin at 8 hrs): The higher values of correlation coefficients for drug release at 8 hrs indicate a good fit. Here, the p-values for X1 and X2 were less than 0.05. Therefore, carbopol 934 and propylene glycol significantly affected in-vitro drug release at 8 hrs Results for regression statistics Y2 is shown in Table 8.
From the 3D surface plot Fig. 6 and regression coefficient values of factors, it was concluded that carbopol 934 had a negative effect on in vitro drug release and propylene glycol had a positive effect on in vitro drug release, so it was concluded that % drug release decreased with increasing concentration of carbopol 934 and increased with increasing concentration of propylene glycol. The significance levels for the X12 and X1X2 coefficients were P= 0.1851and 0.2188, respectively, so they were omitted from the full model to generate a reduced model. The coefficients X1, X2, and X22 were significant at P<0.05; therefore, they were retained in the reduced models 21, 22, 23.
FIG. 6: 3D SURFACE PLOT OF RESPONSE Y2
TABLE 8: REGRESSION STATISTICS Y2
R-Squared | 0.995 | |
Adj R-Squared | 0.992 | |
Source | Sum of Squares | P value |
Model (Quadratic) | 1228.29 | < 0.0001 |
X1 | 318.28 | < 0.0001 |
X2 | 652.92 | < 0.0001 |
X12 | 1.79 | 0.1851 |
X22 | 232.24 | < 0.0001 |
X1X2 | 1.51 | 0.2188 |
Full model equation Y2= 78.40-7.28X1+10.43X2+0.81X12- 9.17X22 -0.61X1X2
Regression Analysis for the Effect of X1 and X2 on Y3 (Cumulative percentage Release of Berberine HCl at 8 hrs): The higher values of correlation coefficients for drug release at 8 hrs indicate a good fit.
Reduced model equation on the basis of p value
Y2=78.40- 7.28X1+10.43X2-9.17X22
Here p Value for X1 and X2 was less than 0.05. Therefore, carbopol 934 and propylene glycol significantly affected in-vitro drug release at 8 hrs Results for regression statistics Y3 is shown in Table 9. From the 3D surface plot Fig. 7 and regression coefficient values of factors, it was concluded that carbopol 934 had a negative effect on in-vitro drug release and propylene glycol had a positive effect on in-vitro drug release, so it was concluded that % drug release decreased with increasing concentration of carbopol 934 and increased with increasing concentration of propylene glycol. The significance levels of the coefficients X12 and X1X2 were P= 0.8817and 0.2458, respectively, so they were omitted from the full model to generate a reduced model. The coefficients X1, X2, and X22 were significant at P<0.05; therefore, they were retained in the reduced models 21, 22, 23.
Reduced model equation based on the p-value
Y3= 32.20-3.31 X1+3.94 X2-2.37 X22
FIG. 7: 3D SURFACE PLOT OF RESPONSE Y3
TABLE 9: REGRESSION STATISTICS Y3
R-Squared | 0.994 | |
Adj R-Squared | 0.991 | |
Source | Sum of Squares | P value |
Model (Quadratic) | 177.13 | < 0.0001 |
X1 | 65.74 | < 0.0001 |
X2 | 93.22 | < 0.0001 |
X12 | 0.003 | 0.8817 |
X22 | 15.52 | < 0.0001 |
X1X2 | 0.23 | 0.2458 |
Full model equation Y3= 32.20-3.31 X1+3.94X2+0.035X12-2.37X22-0.24 X1X2
Regression Analysis for the Effect of X1 and X2 on Y4 (Cumulative Percentage Release of Curcuminoids at 8 hrs): The higher values of correlation coefficients for drug release at 8 hrs indicate a good fit.
Here p Value for X1 and X2 was less than 0.05. Therefore, carbopol 934 and propylene glycol significantly affected in-vitro drug release at 8 hrs Results for regression statistics Y4 is shown in Table 10.
From the 3D surface plot Fig. 8 and regression coefficient values of factors, it was concluded that carbopol 934 had a negative effect on in-vitro drug release and propylene glycol had a positive effect on in-vitro drug release, so it was concluded that % drug release decreased with increase in the concentration of carbopol 934 and increased with increasing concentration of propylene glycol. The significance levels of the coefficients X12 and X1X2 were P= 0.6123 and 0.0736, respectively, so they were omitted from the full model to generate a reduced model. The coefficients X1, X2, and X22 were significant at P<0.05; therefore, they were retained in the reduced models 21, 22, 23.
Reduced model equation based on a p-value
Y4= 61.23-5.86 X1+7.03 X2 -5.32 X22
FIG. 8: 3D SURFACE PLOT OF RESPONSE Y4
TABLE 10: REGRESSION STATISTICS Y4
R-Squared | 0.997 | |
Adj R-Squared | 0.996 | |
Source | Sum of Squares | P value |
Model (Quadratic) | 592.57 | < 0.0001 |
X1 | 205.92 | < 0.0001 |
X2 | 296.10 | < 0.0001 |
X12 | 0.062 | 0.6123 |
X22 | 78.18 | < 0.0001 |
X1X2 | 0.97 | 0.0736 |
Full model equation Y4 = 61.23-5.86X1 + 7.03X2 + 0.15 X12-5.32 X22-0.49 X1X2
Optimization of Formulation: The optimum formulation was chosen based on the criteria of minimum & maximum values of the response variables. From Fig. 9, we can conclude that the batch with X1 = 0.79 and X2 =14.60 was selected as the optimized batch with desirability 1.
TABLE 11: RESULTS OF EVALUATION PARAMETERS OF OPTIMIZED BATCH (D0)
Parameters | Results |
Viscosity (cps) | 78123.67±0.69 |
pH | 6.4±0.18 |
Spreadability (cm.gm/sec) | 4.73 |
% Drug content of quercetin | 99.89±0.38 |
%Drug content of berberine HCl | 98.1± 1.42 |
%Drug content of curcuminoids | 98.75± 0.75 |
Cumulative % drug release of quercetin at 8hrs | 85.99±1.03 |
Cumulative % drug release of berberine HCl at 8hrs | 35.38±0.45 |
Cumulative % drug release of curcuminoids at 8hrs | 70.28±1.18 |
FIG. 9: OPTIMIZED BATCH FROM OVERLAY PLOT
TABLE 12: COMPARISON BETWEEN RESPONSES OF OPTIMIZED BATCH (D0)
Evaluation parameters | Actual value | Predicted value | % Error |
Viscosity (cps) | 78123.67 | 79552.7 | 1.80 |
Cumulative %drug release of quercetin at 8hrs | 85.99 | 87.32 | 1.52 |
Cumulative %drug release of berberine HCl at 8hrs | 35.38 | 36.77 | 3.78 |
Cumulative %drug release of curcuminoids at 8hrs | 70.28 | 68.53 | 2.55 |
The actual response of the optimized batch was measured and compared with the predicted response of the checkpoint batch, and % Error was found to be less than 5%. So it shows a good correlation between observed and predicted values. Hence it was concluded that this design was valid.
TABLE 13: ACCELERATED STABILITY STUDY OF GEL FORMULATION
Stability
conditions |
Sampling time | pH | Viscosity(cps) | Drug content (%) | Cumulative percent drug release at 8 hrs | ||||
Quercetin | Berberine HCl | Curcuminoids | Quercetin | Berberine HCl | Curcuminoids | ||||
Accelerated condition (40±2°C and75±5% RH) (Batch D0) | Initial (0 day) | 6.4± 0.18 | 78123.67± 5.13 | 99.89± 0.38 | 98.1± 1.42 | 98.75± 0.75 | 85.99 | 35.38 | 70.28 |
30 days | 6.45± 0.32 | 78134± 4.58 | 98.37± 0.66 | 99.98± 0.73 | 99.53± 1.34 | 86.16 | 34.59 | 69.34 | |
60 days | 6.43± 0.21 | 78132± 2.65 | 99.67± 1.36 | 99.39± 1.07 | 99.87± 0.44 | 86.32 | 35.15 | 68.4 | |
90 days | 6.33± 0.45 | 78127.33± 2.08 | 98.15± 2.31 | 99.28± 1.42 | 98.37± 1.73 | 85.17 | 36.12 | 70.13 |
This study showed that drugs remained stable in gel formulation at accelerated conditions for 90 days. No significant variations in pH, viscosity, % drug content and cumulative percent drug release at 8 hrs were observed at mentioned conditions.
CONCLUSION: The present investigation was to develop, optimize and evaluate herbal gel formulation using polymers such as carbopol 934 and propylene glycol. An FTIR investigation of drug excipient compatibility revealed no interactions between drugs and excipients. From all parameters and experimental design evaluation, it was concluded that viscosity increased with increasing carbopol 934 and propylene glycol concentrations; cumulative percent drug release decreased with increasing carbopol 934 concentrations and increased with increasing propylene glycol concentrations.
ACKNOWLEDGEMENT: Nil
CONFLICTS OF INTEREST: The authors declare no conflict of interest.
REFERENCES:
- Janani SK and Sureshkumar R: A comprehensive review on acne, its pathogenesis, treatment, in-vitro and in-vivo models for induction and evaluation methods. International J of Pharma Sciences and Res 2019; 10(7): 3155-3177.
- Eichenfield DZ, Sprague J and Eichenfield LF: Management of Acne vulgaris: A review. Journal of the American Medical Association 2021; 326(20): 2055-2067.
- Berry K, Lim J and Zaenglein AL: Acne vulgaris: Treatment made easy for the primary care physician. Pediatric Annals 2020; 49(3): 109-e115.
- Habeshian KA and Cohen BA: Current issues in the treatment of Acne vulgaris. Pediatrics 2020; 145(2): 225-230.
- Singh V, Verma R, Kaushik D and Mittal V: Recent patents on phytoconstituents-based formulations for the treatment of acne infection: A review. Recent Patents on Anti-Infective Drug Discovery 2020; 15(2): 119-136.
- Batubara I, Kuspradini H, Muddathir AM and Mitsunaga T: Intsia palembanica wood extracts and its isolated compounds as Propionibacterium acnes lipase inhibitor. Journal of Wood Science 2014; 60: 169-174.
- Majewski G, Bohm R and Ross M: Acne treatment compositions and methods of use. US20080070875A1. 2008.
- Madan S, Nehate C, Barman TK, Rathore AS and Koul V: Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: in-vitro and in-vivo Drug Development and Industrial Pharmacy 2019; 45(3): 395-404.
- Chi-Hsien Liu and Hsin-Ying Huang: In-vitro Anti-Propionibacterium activity by curcumin containing vesicle system. Chemi and Pharma Bulletin 2013; 61(4): 419-425.
- Patel K and Zaveri M: Spectrophotometric multicomponent determination of quercetin, berberine HCl and curcumin by double divisor ratio spectra derivative method. Intern J of Botany Studies 2021; 6(5): 257-61
- Slobodnikova L, Kostalova D, Labudova D, Kotulova D and Viktor Kettmann: Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytotherapy Research 2004; 18: 674-676.
- Tseng, Po-Yuan, Lin, I, Tsai, Chen-En, Chen and Chih-Kuang: Therapeutic uses of Berberine formulations. WO 2016/210230 Al. 2016.
- Pavia D, Lampman G and Kriz G: Introduction to spectroscopy: A guide for students of organic chemistry. Thomson Learning, Edition 2013; 3: 14-101.
- Hosadurga R, Rao SN, Jose J, Rompicharla N, Shakil M and Shashidhara R: Evaluation of the efficacy of 2% curcumin gel in the treatment of experimental periodontitis. Pharmacognosy Research 2014; 6(4): 326-333.
- Patel NA, Patel NJ and Patel RP: Formulation and evaluation of curcumin gel for topical application. Pharmaceutical Development and Technology 2009; 14(1): 80-89
- Qureshi M, Qadir A, Aqil M, Sultana Y, Warsi MH, Ismail MV and Talegaonkar S: Berberine loaded dermal quality by design adapted chemically engineered lipid nano-constructs-gel formulation for the treatment of skin acne. Journal of Drug Delivery Science and Technology 2021; 66: 102805.
- Ramadon D, Anwar E and Harahap Y: In-vitro penetration and bioavailability of novel transdermal quercetin-loaded ethosomal gel. Indian Journal of Pharmaceutical Sciences 2017; 79(6): 948-956
- Prasad SB, Kaur D and Yashwant: Formulation of topical gel from extract of Berberis aristata DC for Acne. International Journal of Drug Delivery Technology 2019; 9(1): 104-108
- Bhaskar G, Arshia S and Priyadarshini S: Formulation and evaluation of topical polyherbal antiacne gels containing Garcinia mangostana and Aloe vera. Pharmacognosy Magazine 2009; 5(19): 93-99.
- Kaur D, Prasad SB and Verma S: Formulation and evaluation gel from extract of Plumbago indica for acne. International Journal of Drug Delivery Technology 2016; 6(3): 95-98.
- Amin MJ, Patel KS, Patel DR, Patel ZP and Bajag JV: Formulation and evaluation of sustained-release pellets of Lornoxicam. International Journal of Applied Pharmaceutics 2021; 13(4): 221-227.
- Kriplani P, Guarve K and Baghel US: Formulation optimization and characterization of transdermal film of curcumin by response surface methodology. Chinese Herbal Medicines 2021; 13: 274-285
- Trivedi H, Patel K, Oza N and Sagar S: Part i: Optimization of Hydralazine Hydrochloride immediate release layer in antihypertensive bilayer tablet. Intern J of Applied Pharmaceutics 2020; 12(5): 227-233.
How to cite this article:
Patel K and Zaveri M: Development, optimization and evaluation of herbal gel formulation. Int J Pharm Sci & Res 2023; 14(3): 1491-99. doi: 10.13040/IJPSR.0975-8232.14(3).1491-99.
All © 2023 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
46
1491-1499
1017 KB
395
English
IJPSR
Kinjal Patel * and Maitreyi Zaveri
Department of Pharmacognosy, K. B. Institute of Pharmaceutical Education and Research, Kadi Sarva Vishwa Vidyalaya, Gandhinagar, Gujarat, India.
kinjal9387@gmail.com
24 June 2022
15 August 2022
21 August 2022
10.13040/IJPSR.0975-8232.14(3).1491-99
01 March 2023